Research Analysts Set Expectations for Jushi FY2024 Earnings

Jushi Holdings Inc. (OTCMKTS:JUSHF) – Equities research analysts at Atb Cap Markets cut their FY2024 earnings estimates for shares of Jushi in a note issued to investors on Sunday, November 10th. Atb Cap Markets analyst F. Gomes now expects that the company will earn ($0.24) per share for the year, down from their previous forecast of ($0.20). The consensus estimate for Jushi’s current full-year earnings is ($0.19) per share. Atb Cap Markets also issued estimates for Jushi’s Q4 2024 earnings at ($0.06) EPS, FY2025 earnings at ($0.19) EPS, FY2026 earnings at ($0.15) EPS, FY2027 earnings at ($0.12) EPS and FY2028 earnings at ($0.11) EPS.

Jushi (OTCMKTS:JUSHF) last posted its quarterly earnings data on Thursday, November 7th. The company reported ($0.08) EPS for the quarter, missing the consensus estimate of ($0.04) by ($0.04). Jushi had a negative net margin of 20.93% and a negative return on equity of 5,529.11%. The firm had revenue of $61.61 million during the quarter, compared to analysts’ expectations of $65.53 million.

Separately, Ventum Cap Mkts upgraded Jushi to a “hold” rating in a research note on Thursday, August 8th.

Jushi Stock Down 4.2 %

JUSHF stock opened at $0.39 on Wednesday. The business has a 50 day moving average of $0.50 and a 200-day moving average of $0.56. The firm has a market cap of $76.69 million, a PE ratio of -1.51 and a beta of -0.86. Jushi has a 12-month low of $0.22 and a 12-month high of $1.09.

Jushi Company Profile

Jushi Holdings Inc, a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for medical and adult-use markets. The company offers flower, extracts, concentrates, edibles, oil, pre-rolls, tinctures, capsules, softgels, cannabis-infused gummies and ultra-premium chocolate, and topicals products, as well as vaporization devices and cartridges under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands.